Researchers Submit Patent Application, "Treatment Of Gastrointestinal Disorders", for Approval (USPTO 20240226122).

A patent application has been submitted for the treatment of gastrointestinal disorders. The composition includes active agents such as cannabinoids and terpenes, which act synergistically to prevent or alleviate disorders of the gastrointestinal tract. The formulation can be in the form of a capsule or tablet, and may include additional ingredients such as microcrystalline cellulose and colloidal silicon dioxide. The method of administration is typically oral. This invention has the potential to address conditions such as irritable bowel syndrome, gastroesophageal reflux disease, Crohn's disease, and ulcerative colitis. [Extracted from the article]